These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 29504544)

  • 1. Circular Inference in Dementia Diagnostics.
    Høilund-Carlsen PF; Barrio JR; Gjedde A; Werner TJ; Alavi A
    J Alzheimers Dis; 2018; 63(1):69-73. PubMed ID: 29504544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flutemetamol (18F): a β-amyloid positron emission tomography tracer for Alzheimer's and dementia diagnosis.
    de Lartigue J
    Drugs Today (Barc); 2014 Mar; 50(3):219-29. PubMed ID: 24696867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Visualization of amyloid with positron emission tomography. Useful improvement in the diagnosis of dementia?].
    Grimmer T; Drzezga A; Kurz A
    Nervenarzt; 2010 May; 81(5):602-6. PubMed ID: 20221742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers.
    Bensaïdane MR; Beauregard JM; Poulin S; Buteau FA; Guimond J; Bergeron D; Verret L; Fortin MP; Houde M; Bouchard RW; Soucy JP; Laforce R
    J Alzheimers Dis; 2016 Apr; 52(4):1251-62. PubMed ID: 27104896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET.
    Brendel M; Schnabel J; Schönecker S; Wagner L; Brendel E; Meyer-Wilmes J; Unterrainer M; Schildan A; Patt M; Prix C; Ackl N; Catak C; Pogarell O; Levin J; Danek A; Buerger K; Bartenstein P; Barthel H; Sabri O; Rominger A
    Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2239-2248. PubMed ID: 28932894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiolabeled bioactive benzoheterocycles for imaging β-amyloid plaques in Alzheimer's disease.
    Yang Y; Cui M
    Eur J Med Chem; 2014 Nov; 87():703-21. PubMed ID: 25305715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.
    Rodriguez-Vieitez E; Saint-Aubert L; Carter SF; Almkvist O; Farid K; Schöll M; Chiotis K; Thordardottir S; Graff C; Wall A; Långström B; Nordberg A
    Brain; 2016 Mar; 139(Pt 3):922-36. PubMed ID: 26813969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [(18)F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: specific detection of advanced phases of amyloid-β pathology.
    Thal DR; Beach TG; Zanette M; Heurling K; Chakrabarty A; Ismail A; Smith AP; Buckley C
    Alzheimers Dement; 2015 Aug; 11(8):975-85. PubMed ID: 26141264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum.
    Murray ME; Lowe VJ; Graff-Radford NR; Liesinger AM; Cannon A; Przybelski SA; Rawal B; Parisi JE; Petersen RC; Kantarci K; Ross OA; Duara R; Knopman DS; Jack CR; Dickson DW
    Brain; 2015 May; 138(Pt 5):1370-81. PubMed ID: 25805643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of amyloid in cognitive impairment after mild traumatic brain injury.
    Yang ST; Hsiao IT; Hsieh CJ; Chiang YH; Yen TC; Chiu WT; Lin KJ; Hu CJ
    J Neurol Sci; 2015 Feb; 349(1-2):99-104. PubMed ID: 25586534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of PET-imaging probes of β-amyloid plaques.
    Koo J; Byun Y
    Arch Pharm Res; 2013 Oct; 36(10):1178-84. PubMed ID: 23812777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Aβ plaque detection and the value of knowing: overcoming challenges to improving patient outcomes in Alzheimer's disease.
    Jovalekic A; Bullich S; Catafau A; de Santi S
    Neurodegener Dis Manag; 2016 Dec; 6(6):491-497. PubMed ID: 27813444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and acceptance of simultaneous amyloid PET/MRI.
    Schütz L; Lobsien D; Fritzsch D; Tiepolt S; Werner P; Schroeter ML; Berrouschot J; Saur D; Hesse S; Jochimsen T; Rullmann M; Sattler B; Patt M; Gertz HJ; Villringer A; Claßen J; Hoffmann KT; Sabri O; Barthel H
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2236-2243. PubMed ID: 27435367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infrequent false positive [
    Ikonomovic MD; Fantoni ER; Farrar G; Salloway S
    Alzheimers Res Ther; 2018 Jun; 10(1):60. PubMed ID: 29935545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Striatal Amyloid Plaques with [18F]flutemetamol: Validation with Postmortem Histopathology.
    Beach TG; Thal DR; Zanette M; Smith A; Buckley C
    J Alzheimers Dis; 2016 Mar; 52(3):863-73. PubMed ID: 27031469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism.
    Rowe CC; Ackerman U; Browne W; Mulligan R; Pike KL; O'Keefe G; Tochon-Danguy H; Chan G; Berlangieri SU; Jones G; Dickinson-Rowe KL; Kung HP; Zhang W; Kung MP; Skovronsky D; Dyrks T; Holl G; Krause S; Friebe M; Lehman L; Lindemann S; Dinkelborg LM; Masters CL; Villemagne VL
    Lancet Neurol; 2008 Feb; 7(2):129-35. PubMed ID: 18191617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
    Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
    Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinic-Based Validation of Cerebrospinal Fluid Biomarkers with Florbetapir PET for Diagnosis of Dementia.
    Álvarez I; Aguilar M; González JM; Ysamat M; Lorenzo-Bosquet C; Alonso A; Tartari JP; Romero S; Diez-Fairen M; Carcel M; Pujalte F; Pastor P
    J Alzheimers Dis; 2018; 61(1):135-143. PubMed ID: 29154286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid-plaque imaging in early and differential diagnosis of dementia.
    Drzezga A
    Ann Nucl Med; 2010 Feb; 24(2):55-66. PubMed ID: 20082230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection.
    Ikonomovic MD; Buckley CJ; Heurling K; Sherwin P; Jones PA; Zanette M; Mathis CA; Klunk WE; Chakrabarty A; Ironside J; Ismail A; Smith C; Thal DR; Beach TG; Farrar G; Smith AP
    Acta Neuropathol Commun; 2016 Dec; 4(1):130. PubMed ID: 27955679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.